DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

Clinical trial NCT06176261 · RECRUITING

Trial details

NCT number: NCT06176261
Sponsor: Nancy Lin, MD
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Breast Cancer Female Metastatic Triple-Negative Breast Carcinoma ER Positive Breast Cancer HER2-negative Breast Cancer HER2 Negative Breast Carcinoma ER-negative Breast Cancer

Start date: 2024-01-08
Primary completion: 2028-01-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.